Literature DB >> 1422978

Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells.

Y Kakai1, T Kawase, T Nakano, Y Mikuni-Takagaki, S Saito.   

Abstract

The effect of ipriflavone (IP) on the proliferation and differentiation of rat osteoblast-like (ROB) cells and human periodontal ligament fibroblasts (HPLF) was studied in the presence and absence of estrogen. ROB cells were isolated from newborn rat calvaria by sequential collagenase digestion and HPLF from the outgrowth of human periodontal ligament in culture. The alkaline phosphatase (ALP) activity, employed as a marker of bone cell differentiation, was significantly enhanced by IP in both cell types; however, the concentration at which IP had a maximal effect was lower in ROB cells than in HPLF (10(-10) versus 10(-7) M, respectively). Cell proliferation judged by DNA content was either constant (ROB cells) or slightly increased (HPLF) by IP up to 10(-10) M, and decreased significantly above that concentration. In addition, the dose-dependent effect of estrogen on the growth and differentiation of each cell type in the presence and absence of IP was also tested. At the concentrations of IP which showed maximum effects in the induction of ALP, 10(-10) M for ROB cells and 10(-7) M for HPLF, IP inhibited DNA increase in an estrogen-independent manner. Estradiol (10(-11)-10(-9) M) itself increased the growth rate of both cell types significantly in a dose-dependent manner. Regardless of the concentrations of estradiol tested, ALP activities of both ROB cells and HPLF were elevated by the addition of IP. The ratio of ALP in the presence and absence of IP was similar over the range of estradiol concentrations tested.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422978     DOI: 10.1007/bf02180243

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  19 in total

1.  Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors.

Authors:  J M Pensler; J A Radosevich; R Higbee; C B Langman
Journal:  J Bone Miner Res       Date:  1990-08       Impact factor: 6.741

2.  Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal.

Authors:  E CHENG; C D STORY; L YODER; W H HALE; W BURROUGHS
Journal:  Science       Date:  1953-08-07       Impact factor: 47.728

3.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

4.  A rapid assay for cellular deoxyribonucleic acid.

Authors:  J E Puzas; D B Goodman
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

5.  Human periodontal cells initiate mineral-like nodules in vitro.

Authors:  N Arceo; J J Sauk; J Moehring; R A Foster; M J Somerman
Journal:  J Periodontol       Date:  1991-08       Impact factor: 6.993

6.  The effect of ipriflavone (TC-80) on bone resorption in tissue culture.

Authors:  M Tsuda; T Kitazaki; T Ito; T Fujita
Journal:  J Bone Miner Res       Date:  1986-04       Impact factor: 6.741

7.  Calcitonin secreting property of ipriflavone in the presence of estrogen.

Authors:  I Yamazaki; M Kinoshita
Journal:  Life Sci       Date:  1986-04-28       Impact factor: 5.037

8.  Effect of ipriflavone on the response of uterus and thyroid to estrogen.

Authors:  I Yamazaki
Journal:  Life Sci       Date:  1986-02-24       Impact factor: 5.037

9.  Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.

Authors:  I Yamazaki; A Shino; Y Shimizu; R Tsukuda; Y Shirakawa; M Kinoshita
Journal:  Life Sci       Date:  1986-03-10       Impact factor: 5.037

10.  Pathogenesis of osteoporosis.

Authors:  B L Riggs
Journal:  Am J Obstet Gynecol       Date:  1987-05       Impact factor: 8.661

View more
  5 in total

1.  A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts.

Authors:  Gaurav Swarnkar; Kunal Sharan; Jawed A Siddiqui; Jay Sharan Mishra; Kainat Khan; Mohd Parvez Khan; Varsha Gupta; Preeti Rawat; Rakesh Maurya; Anil K Dwivedi; Sabyasachi Sanyal; Naibedya Chattopadhyay
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Model for in vitro investigation of bone mineralization.

Authors:  G G Ecsedi
Journal:  Agents Actions       Date:  1994-03

3.  Ipriflavone improves bone density and biomechanical properties of adult male rat bones.

Authors:  R Civitelli; S H Abbasi-Jarhomi; L R Halstead; A Dimarogonas
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

4.  Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.

Authors:  S L Cheng; S F Zhang; T L Nelson; P M Warlow; R Civitelli
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

5.  Ipriflavone promotes proliferation and osteogenic differentiation of periodontal ligament cells by activating GPR30/PI3K/AKT signaling pathway.

Authors:  Yuanyuan Han; Xuxia Wang; Dan Ma; Xiaoxiao Wu; Panpan Yang; Jun Zhang
Journal:  Drug Des Devel Ther       Date:  2018-01-11       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.